YAP1 and hepatocellular carcinoma: The deregulation of the YAP expression has been reported in a broad range of different human cancers, including non-small cell lung carcinoma (nSCLC) [8], ovarian [9], hepatocellular carcinoma (HCC) [10], pancreatic cancer [11], and malignant melanoma [12].